When was NeuroControl founded?

NeuroControl was founded in 2011.

Where is NeuroControl located?

NeuroControl is headquartered in Delft, Netherlands.

How many employees does NeuroControl have?

As of Jul 01, 2024, the latest employee count at NeuroControl is 1.

Is NeuroControl a funded company?

NeuroControl is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does NeuroControl rank among its competitors?

NeuroControl ranks 108th amongst 96 active competitors, of which 20 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was LIFESCAPES, which secured $3.74M in Jun, 2026.

Who are the top competitors of NeuroControl?

NeuroControl's top competitors include Precision Neuroscience, Blackrock Neurotech and Nexstim. Among them, LIFESCAPES secured the most recent funding round in June, 2026.

NeuroControl - 2026 Company Profile & Competitors

Company Details

NeuroControl focuses on exploiting neuroplasticity to develop innovative tools for treatment and prevention of disabilities caused by chronic neurological diseases such as Stroke, Parkinson’s disease and Neuropathic pain syndromes. The company conducts research in neuroscience, signal-processing with neurology, and robotics with rehabilitation medicine at achieve its aims. Neurocontrol is a Centre of Research Excellence (CoRE) established in 2011 as part of the IMDI initiative, selected by the Netherlands Organization for Health Research and Development as one of the spearheads of Medical Technology research in the Netherlands. It is a close collaboration between the TU Delft, Utwente, VUMC, VU, Radboudumc, LUMC, ErasmusMC, several companies, rehabilitation centres and other institutions and patient unions.

Website: neurocontrol.nl
Email ID: *****@gmail.com

Key Metrics

Founded Year

2011

Location

Delft, Netherlands

Stage

Unfunded

Ranked

108^th among 112 competitors

Employee Count

1 as on Jul 01, 2024

Similar Companies

Precision Neuroscience & 110 more

View NeuroControl's full profile

NeuroControl has not raised any funding rounds yet.

NeuroControl's employee count trend

NeuroControl has 1 employees as of Jul 24. Here is NeuroControl's employee count trend over the years:

Uncover NeuroControl's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroControl include Precision Neuroscience, Blackrock Neurotech and Nexstim. Here is the list of Top 10 competitors of NeuroControl, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Precision Neuroscience 2021, New York City (United States), Series C	Developed of brain-computer interface tool for medical treatment and drug development	$183M	Steadview, B Capital & 10 others	65/100
2nd	Blackrock Neurotech 2008, Salt Lake City (United States), Acquired	Developer of medical devices for neurological therapies	$22.4M	re.Mind Capital, Cavendish Privateers & 12 others	62/100
3rd	Nexstim 2000, Helsinki (Finland), Public	Provider of noninvasive brain stimulation for rehabilitating stroke patients	$29.7M	Lundbeck Foundation, Kreos Capital & 8 others	52/100
4th	g.tec 1999, Schiedlberg (Austria), Funding Raised	Provider of high-performance brain-computer interfaces and neurotechnologies for invasive and non-invasive recordings	-	EIC Fund, Europa	51/100
5th	Helius Medical 2014, Newtown Square (United States), Public	Developer of neurological rehabilitation medical devices	$391K	Pantera Capital, Summer Capital Management Company ... & 14 others	51/100
6th	LIFESCAPES 2018, Minato City (Japan), Series A	Developer of brain-machine interface devices for neurorehabilitation	$3.74M	Beyond Next Ventures, Shionogi & 9 others	50/100
7th	BIONIK 2010, Toronto (Canada), Public	Provider of assistive and rehabilitation hardware and software solutions	-	Ginger Capital, MBX Capital & 3 others	48/100
8th	Synergia Medical 2013, Mont Saint Guibert (Belgium), Series B	Developer of an active implantable neurostimulator and contact-less patient monitoring system	$14.2M	Newton Biocapital, SFPI & 8 others	47/100
9th	Minnetronix Medical 1996, Saint Paul (United States), Acquired	Manufacturer of multiple devices for neurocritical patients	$20M	Altaris, NIH & 1 others	46/100
10th	Endonovo Therapeutics 2011, Los Angeles (United States), Public	Bioelectronic devices and therapies for regenerative medicine	-	Kodiak Capital, Azure Capital Partners & 2 others	46/100
108th	NeuroControl 2011, Delft (Netherlands), Unfunded	Neuroplasticity to treat neurological diseases such as Stroke, Parkinson's disease, and Neuropathic pain	-	-	15/100